1. Home
  2. LXRX vs ESEA Comparison

LXRX vs ESEA Comparison

Compare LXRX & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ESEA
  • Stock Information
  • Founded
  • LXRX 1995
  • ESEA 2005
  • Country
  • LXRX United States
  • ESEA Greece
  • Employees
  • LXRX N/A
  • ESEA N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ESEA Marine Transportation
  • Sector
  • LXRX Health Care
  • ESEA Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • ESEA Nasdaq
  • Market Cap
  • LXRX 228.8M
  • ESEA 208.2M
  • IPO Year
  • LXRX 2000
  • ESEA 2006
  • Fundamental
  • Price
  • LXRX $0.63
  • ESEA $38.59
  • Analyst Decision
  • LXRX Buy
  • ESEA Buy
  • Analyst Count
  • LXRX 4
  • ESEA 1
  • Target Price
  • LXRX $3.67
  • ESEA $53.00
  • AVG Volume (30 Days)
  • LXRX 4.1M
  • ESEA 23.0K
  • Earning Date
  • LXRX 05-13-2025
  • ESEA 06-10-2025
  • Dividend Yield
  • LXRX N/A
  • ESEA 6.77%
  • EPS Growth
  • LXRX N/A
  • ESEA N/A
  • EPS
  • LXRX N/A
  • ESEA 16.20
  • Revenue
  • LXRX $31,213,000.00
  • ESEA $212,897,313.00
  • Revenue This Year
  • LXRX N/A
  • ESEA $4.83
  • Revenue Next Year
  • LXRX $46.60
  • ESEA $3.27
  • P/E Ratio
  • LXRX N/A
  • ESEA $2.37
  • Revenue Growth
  • LXRX 1251.21
  • ESEA 12.43
  • 52 Week Low
  • LXRX $0.28
  • ESEA $24.58
  • 52 Week High
  • LXRX $2.45
  • ESEA $41.43
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 51.48
  • ESEA 66.63
  • Support Level
  • LXRX $0.62
  • ESEA $37.52
  • Resistance Level
  • LXRX $0.72
  • ESEA $38.69
  • Average True Range (ATR)
  • LXRX 0.05
  • ESEA 1.12
  • MACD
  • LXRX -0.00
  • ESEA -0.16
  • Stochastic Oscillator
  • LXRX 59.81
  • ESEA 68.56

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

Share on Social Networks: